Advocacy group Public Citizen petitions FDA to ban direct-to-consumer prescription drug ads

Public Citizen has filed a petition with the U.S. Food and Drug Administration calling for a ban on direct-to-consumer advertising of prescription medicines.

The group argues that such ads are designed to persuade rather than inform, often using emotional appeals and visual tricks that highlight benefits while downplaying risks.

The request comes as the current administration has signaled a crackdown on what it deems deceptive drug advertising, announcing plans for stricter rules and enforcement last September.

Public Citizen hopes the FDA will act on the petition, adding to a wave of letters and public pressure aimed at tightening oversight of prescription drug promotion.